- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07225725
Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC) (ENRICH-HNC)
Community Health Support for Emergency Department-Presenting Head and Neck Cancer Patients: A Pilot to Improve Access to Timely Care
Patients diagnosed with head and neck cancer (HNC) after presenting to an emergency department (ED) often face significant delays in diagnosis and treatment. These patients are frequently younger, underinsured, and experience multiple socioeconomic and systems-level barriers to accessing timely cancer care. Delays of more than 30 days have been associated with worse outcomes, including higher recurrence rates and reduced survival.
This pilot study will evaluate the feasibility and early impact of a community-based navigation program designed to improve access to timely care for ED-presenting HNC patients. The study embeds trained Community Health Support Specialists (CHSS) from the Engaging Navigators to Reduce Inequities in Cancer Health (ENRICH) program into the ED-to-treatment pathway. After ED discharge, CHSS staff will contact participants by telephone or text message to identify barriers to care-such as transportation, insurance, housing, or communication challenges-and connect them with appropriate community or institutional resources.
All participants will receive the CHSS navigation intervention. Outcomes will be compared with a historical cohort of similar ED-presenting HNC patients treated prior to program implementation. The primary outcomes are time from ED discharge to diagnostic biopsy and time from ED discharge to initiation of definitive treatment. Secondary outcomes include feasibility, measured as the proportion of participants who complete CHSS navigation, and exploratory analyses of the types of barriers identified and resolved.
Findings from this pilot will generate preliminary data to inform larger studies aimed at improving access, reducing disparities, and accelerating treatment for head and neck cancer patients who first present in the emergency setting.
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a single-arm, prospective pilot study evaluating the feasibility and process impact of embedding Community Health Support Specialist (CHSS) navigation within the emergency department (ED)-to-treatment pathway for patients with newly suspected or newly diagnosed head and neck cancer (HNC). The study will be conducted at two University of Tennessee Health Science Center (UTHSC)-affiliated hospitals: Methodist University Hospital and Regional One Health.
Eligible participants are adults aged 18 years or older who present to the ED with a new or suspected HNC involving the oral cavity, oropharynx, hypopharynx, larynx, salivary glands, skin, sinonasal region, nasopharynx, thyroid, or an unknown primary. Patients with prior established oncology care for HNC, those enrolled in hospice, incarcerated individuals, or patients who cannot be contacted by telephone will be excluded.
During routine clinical care in the ED, otolaryngology residents identify potentially eligible patients and introduce the study using an IRB-approved consent disclosure statement. ED activities are limited to screening and obtaining permission to contact; no informed consent or HIPAA authorization occurs in the ED.
After ED discharge, a trained study team member conducts the full informed consent process electronically using REDCap eConsent. Participants may review the consent form remotely with study staff and provide electronic signature with date/time acknowledgment. Only participants who complete electronic informed consent and HIPAA authorization are enrolled.
Following enrollment, CHSS specialists initiate outreach within 72 hours of ED discharge and provide structured, non-clinical navigation support through at least two telephone or text-based contacts prior to initiation of definitive cancer treatment. CHSS activities focus on identifying and addressing barriers to care, including transportation challenges, insurance or financial barriers, housing instability, and communication gaps. CHSS staff do not provide medical advice, schedule clinical appointments, or alter treatment plans. All encounters are documented using standardized REDCap case report forms.
The primary outcomes are (1) time from ED discharge to diagnostic biopsy and (2) time from ED discharge to initiation of definitive treatment. Secondary outcomes include feasibility, measured as the proportion of enrolled participants who complete CHSS navigation. Exploratory outcomes describe the types of social barriers identified, the proportion of barriers resolved, and patterns of navigation support.
Study data are entered and stored in REDCap, a secure, HIPAA-compliant database hosted by UTHSC. Outcomes for the pilot cohort will be compared with a historical control group of similar ED-presenting HNC patients treated at UTHSC-affiliated hospitals in the 24 months preceding program implementation. Analyses will use descriptive, non-parametric, and regression methods to estimate feasibility metrics and effect sizes to inform future multi-site studies.
This study is funded through the UTHSC Cancer Center's Access to Cancer Care Pilot Project and builds upon the Tennessee Department of Health-supported ENRICH program, which deploys CHSS specialists to reduce disparities in cancer care. Results will inform potential expansion of this navigation model to improve equity, timeliness, and outcomes for head and neck cancer patients presenting through the emergency department.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Justin M Soffer, MD
- Phone Number: 321-287-7574
- Email: jsoffer@uthsc.edu
Study Contact Backup
- Name: David Schwartz, MD
- Phone Number: 516-234-8090
- Email: dschwar4@uthsc.edu
Study Locations
-
-
Florida
-
Orlando, Florida, United States, 32819
- Methodist University Hospital
-
Contact:
- Justin M Soffer, MD
- Phone Number: 321-287-7574
- Email: jsoffer@uthsc.edu
-
-
Tennessee
-
Memphis, Tennessee, United States, 38103
- Regional One Health
-
Contact:
- Justin M Soffer, MD
- Phone Number: 321-287-7574
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Age 18 years or older
- Presentation to the emergency department (ED) with a new or suspected head and neck cancer (including oral cavity, oropharynx, hypopharynx, larynx, salivary gland, cutaneous, sinonasal, nasopharyngeal, thyroid, or metastatic disease with unknown primary)
- Residence within the regional catchment area of participating UTHSC-affiliated hospitals (Methodist University Hospital or Regional One Health)
- Ability to provide informed consent electronically using REDCap eConsent after ED discharge
- Has a valid telephone number for post-discharge contact
Exclusion Criteria
- Prior or ongoing established head and neck oncology care at the time of ED presentation
- Currently receiving hospice or palliative-only care
- Incarcerated individuals
- Inability to complete electronic informed consent (e.g., lack of decisional capacity or inability to complete consent even with staff assistance)
- Lacks reliable telephone access or is unable to be reached after three documented contact attempts by study staff
- Non-English or non-Spanish speaking when interpreter services are unavailable
- Expected survival less than four weeks, as determined by the treating clinical team
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Community Health Support Specialist (CHSS) Navigation
Participants will receive structured, non-clinical navigation support from a trained Community Health Support Specialist (CHSS) initiated after emergency department discharge.
CHSS outreach will occur by telephone or text message and will focus on identifying social and logistical barriers to timely cancer care (e.g., transportation, insurance, housing, communication), providing appropriate resource referrals, and reinforcing communication between patients and clinical care teams as needed.
Each participant will receive a minimum of two CHSS contacts prior to initiation of definitive cancer treatment.
|
This intervention consists of structured, non-clinical navigation delivered by trained Community Health Support Specialists (CHSS) as part of the Engaging Navigators to Reduce Inequities in Cancer Health (ENRICH) program.
Following emergency department discharge and completion of electronic informed consent, CHSS staff conduct outreach by telephone or text message to identify and address social and logistical barriers to timely head and neck cancer care.
Navigation activities may include assistance with transportation resources, insurance or financial navigation, connection to housing or community services, and reinforcement of communication between patients and clinical care teams.
CHSS staff do not provide medical advice, schedule clinical appointments, or alter treatment plans.
All navigation encounters are documented using standardized REDCap instruments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time From Emergency Department (ED) Presentation to Diagnostic Biopsy (Days)
Time Frame: Up to 90 days after ED discharge
|
Interval (days) between the date of ED discharge from the index visit and the date of the first diagnostic biopsy procedure performed to evaluate suspected head and neck cancer.
|
Up to 90 days after ED discharge
|
|
Time From Emergency Department (ED) Presentation to Treatment Initiation (Days)
Time Frame: Up to 90 days after ED discharge
|
Interval (days) between the date of ED discharge from the index visit and the start date of definitive treatment (surgery, radiation, systemic therapy, or combined modality) for head and neck cancer.
|
Up to 90 days after ED discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Community Health Support Specialist (CHSS) Navigation
Time Frame: Up to 90 days after enrollment
|
Proportion of enrolled participants who complete the CHSS navigation protocol, defined as documentation of at least two completed CHSS outreach contacts (telephone or text message) prior to initiation of definitive treatment or study completion.
|
Up to 90 days after enrollment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number and Types of Social Barriers Identified During CHSS Encounters
Time Frame: Up to 90 days after enrollment
|
Count and categorization of distinct social or logistical barriers (e.g., transportation, insurance, housing, communication) documented by CHSS staff across all encounters using standardized REDCap instruments.
|
Up to 90 days after enrollment
|
|
Number of Barriers Resolved Through CHSS Intervention
Time Frame: Up to 90 days after enrollment
|
Count of barriers documented as resolved by CHSS staff using standardized REDCap instruments.
Resolution is defined as documentation that the participant was successfully linked to an appropriate resource/service or that the identified barrier was otherwise addressed.
|
Up to 90 days after enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David Schwartz, MD, University of Tennessee
Publications and helpful links
Helpful Links
- UTHSC news release describing the ENRICH program, a state-funded initiative led by Drs. Schwartz and Stewart to improve cancer care access through community health support specialists in West Tennessee.
- Official UTHSC Cancer Center webpage providing information about cancer research, pilot grant programs, and access-to-care initiatives supported by the institution.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25-10971-XP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Neoplasms
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
University of California, San FranciscoActive, not recruitingHead and Neck Cancer | Head and Neck Neoplasms | Head and Neck CarcinomaUnited States
-
AZ Sint-Jan AVActive, not recruiting
-
Yale UniversityRecruitingHead and Neck Cancer | Head and Neck TraumaUnited States
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
DyameoGETTEC (Groupe d'Etude des Tumeurs de la Tête et du Cou)Not yet recruiting
-
OHSU Knight Cancer InstituteCompletedHead and Neck CarcinomaUnited States
-
Hospices Civils de LyonCompleted
-
University College, LondonWithdrawnHead and Neck Cancer
Clinical Trials on Community Health Support Specialist (CHSS) Navigation
-
University of CalgaryAlberta Innovates Health Solutions; Canadian Diabetes AssociationCompletedHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
Medstar Health Research InstituteGeorgetown University; George Washington University; Howard UniversityActive, not recruitingBreast Cancer | Prostate Cancer | Social Determinants of Health | Disparities | Health EquityUnited States
-
Stanford UniversityCalifornia Initiative to Advance Precision Medicine; Pacific Cancer Care; The... and other collaboratorsCompleted
-
VA Office of Research and DevelopmentDurham VA Medical CenterNot yet recruitingUsing Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans (PATH)Cancer | Dementia | Renal Disease | Obstructive Pulmonary DiseaseUnited States
-
University of PennsylvaniaWestat; City of Phladelphia - Office of Community Empowerment and OpportunityRecruitingCardiovascular Diseases | Disparities | Community Health Workers | Social Determinants of Health (SDOH)United States
-
VA Office of Research and DevelopmentJames J. Peters Veterans Affairs Medical Center; VISN 2 Mental Illness Research... and other collaboratorsRecruitingHealth | Reintegration Difficulties | Suicidal Ideation and Behaviors | ConnectednessUnited States
-
University of Texas at AustinCompleted
-
Public Health - Seattle and King CountyNational Institute of Environmental Health Sciences (NIEHS)Completed
-
University of Alabama at BirminghamAmerican Heart AssociationActive, not recruitingHypertension | Prehypertension | Blood PressureUnited States
-
University GhentCompletedCovid 19 | Mental Health Impairment | Social IsolationBelgium